Items where authors include "Inra, J."

Article

Miller, T.M., Cudkowicz, M.E., Shaw, P.J. et al. (428 more authors) (2025) Long-term tofersen in SOD1 amyotrophic lateral sclerosis. JAMA Neurology, 83 (2). ISSN 2168-6149

Lovett, A., Chary, S., Babu, S. et al. (15 more authors) (2025) Serious neurologic adverse events in Tofersen clinical trials for amyotrophic lateral sclerosis. Muscle & Nerve, 71 (6). pp. 1006-1015. ISSN 0148-639X

van den Berg, L.H., Rothstein, J.D., Shaw, P.J. orcid.org/0000-0002-8925-2567 et al. (26 more authors) (2024) Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study. The Lancet Neurology, 23 (9). pp. 901-912. ISSN 1474-4422

Proceedings Paper

Miller, T.M., Cudkowicz, M.E., Shaw, P.J. orcid.org/0000-0002-8925-2567 et al. (9 more authors) (2025) Final results from the phase 3 VALOR trial and open-label extension evaluating efficacy and safety of tofersen in adults with SOD1-ALS. In: Muscle & Nerve. 24th Annual Meeting of the Northeast ALS Consortium, 07-10 Oct 2025, Florida, USA. , S97-S97.